15th Annual Comprehensive Hematology & Oncology Review Course (September 23 - 27, 2024)

Monday, September 23, 2024, 7:15 AM - Friday, September 27, 2024, 5:00 PM, Other, Seattle, WA

AMA PRA Category 1 Credits™ (36.75 hours), ABIM MOC Part 2 (36.75 hours), Non-Physician (36.75 hours)

This 54-topic program covers data supporting guidelines, recommendations, and recent advances regarding therapeutic options for patients with solid tumors and hematologic disorders. After completing the program, learners will have a deeper understanding of the pathogenesis, diagnostic evaluation, and therapeutic modalities available for a breadth of solid tumors and hematologic disorders. The material can be used to help prepare attendees for certifying and re-certifying exams.

REGISTRATION CLOSED

For attendee registration visit the Fred Hutch event website for more event details and the registration link: Register Today!

1. Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common malignant hematological diseases.
2. Explain the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common solid tumor malignancies.
3. Integrate guideline-based treatments into clinical practice while personalizing care appropriately for the patient.
4. Organize new therapeutic and diagnostic approaches into clinical practice as appropriate.

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this Live Activity for a maximum of 36.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Credits: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 36.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Course Co-Chairs

Ryan D. Cassaday, MD Associate Professor Division of Hematology Assistant Member, Clinical Research Division (FHCRC) Attending Physician, Hematologic Malignancies Program University of Washington | Fred Hutchinson Cancer Research Center Course Co-Chair

Andrew L. Coveler, MD Associate Professor Division of Medical Oncology Associate Member, Clinical Research Division (FHCRC) Director, Pancreas Cancer Specialty Clinic (FHCRC) University of Washington | Fred Hutchinson Cancer Research Center Course Co-Chair

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited activity, including faculty, planners, reviewers or others in control of content are required to disclose all relevant financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the start of the activity.

Exhibitor has reached maximum capacity, email [email protected] if you are interested in being added to the waitlist to exhibit.

Thank you to the following supporters.

 

Premium Level
Breast Cancer

 

Standard Level
Oncology		Rare Disease